Andreas:
CRXA and "the" vaccine take top spot at Medscape today......
Online Coverage from the
American Society of Clinical Oncology
May 16-19, 1998
c Medscape, Inc.
Antitumor Peptide Vaccine Induces Specific T-Cell
Immunity to HER-2/neu
Speaker: Mary Disis, MD, University of Washington
Reporter: Philip Schulman, MD, North Shore University Hospital, Manhasset, NY
Reviewer: Eric K. Rowinsky, MD, Cancer Therapy and Research Center, San Antonio, Tex
Introduction
A peptide-based vaccine elicited specific T-cell responses against both HER-2
peptides and the HER-2 protein (snip)
Miljenko Zuanic had predicted that CRXA was going to pop on this news, and I just started watching it over the weekend. Congrats!
Rick |
